Markets:

Overview

News

Currencies

International

Treasuries

Prelude Therapeutics Incorporated - Common Stock (NQ:PRLD)

4.910 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prelude Therapeutics Incorporated - Common Stock

< Previous 1 2 3 4 5 Next >

Prelude Therapeutics Announces Strategic Business Update

November 04, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors

November 04, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

These stocks are moving in today's after hours session ↗

November 03, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 03, 2025

Via Benzinga

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting

November 03, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Tuesday's session: top gainers and losers ↗

October 21, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors

October 17, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Prelude Cuts Q2 Losses and Costs 13% ↗

August 14, 2025

Via The Motley Fool

Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

August 14, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

June 02, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 27, 2025

Via Benzinga

Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 06, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Prelude Therapeutics to Participate in Citizens Life Sciences Conference

May 01, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Prelude Announces Presentations at 2025 AACR Annual Meeting

April 25, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session. ↗

March 28, 2025

Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 28, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Friday's session. ↗

March 28, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 28, 2025

Via Benzinga

Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

March 28, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

March 27, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 14, 2025

Via Benzinga

Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025

March 10, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference

March 05, 2025

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 11, 2025

Via Benzinga

Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

February 11, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

February 10, 2025

The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies

December 11, 2024

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit

November 27, 2024

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

November 06, 2024

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.